Dudediligence.

Moderna, Inc

MRNANASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.86BSep ’24$966.0MDec ’24$108.0MMar ’25$142.0MJun ’25$1.02BSep ’25$678.0MDec ’25$389.0MMar ’26$145.0MJun ’26
Net income, by quarter
$13.0MSep ’24−$1.12BDec ’24−$971.0MMar ’25−$825.0MJun ’25−$200.0MSep ’25−$826.0MDec ’25−$1.34BMar ’26−$782.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$18.47B$19.26B$6.85B$3.24B$1.94B
Gross profit$15.85B$13.85B$2.15B$1.77B$1.08B
Operating income$13.30B$9.42B−$4.24B−$3.94B−$3.07B
Net income$12.20B$8.36B−$4.71B−$3.56B−$2.82B
Operating cash flow$13.62B$4.98B−$3.12B−$3.00B−$1.87B
Free cash flow$13.34B$4.58B−$3.83B−$4.05B−$2.06B
Cash$6.85B$3.21B$2.91B$1.93B$2.60B
Debtnone on filenone on filenone on file$0.00$590.0M
Shares outstanding403.0M385.0M382.0M386.0M394.0M